Two patented botanical extracts were associated with significant increases in GLP-1 blood levels and significant weight loss in 90 overweight/obese subjects.
The acquisition includes dsm-firmenich’s fish oil business for foods, beverages, supplements, and pharmaceuticals, and the MEG-3 brand and its facilities.
The global retailer launched a new house brand, and partnered with several pet care brands to offer products designed to support the health of dogs and cats.
Private label brand PharmaLinea’s vitamin and nucleotide complex appeared to offer greater benefit than placebo in a population undergoing physical therapy.
The yeast-derived, human-equivalent lactoferrin ingredient is formulated to digest similarly to human lactoferrin, compared to a bovine-sourced counterpart.
The cannabinoid was found to improve sleep quality with no side effects in 1,000 people, at levels more significant than standard-dose melatonin supplements.